What Does BioCryst Pharmaceuticals, Inc. Do?

Total employees624
HeadquartersDurham
Founded1986

BioCryst Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, developing, and commercializing novel, oral, small-molecule medicines for patients with rare and serious diseases. Their focus areas include hereditary angioedema (HAE) and other complement-mediated diseases, as well as virology. Their flagship product, ORLADEYO® (berotralstat), is an oral, once-daily therapy for preventing HAE attacks. BioCryst's pipeline includes potential treatments for paroxysmal nocturnal hemoglobinuria (PNH), influenza, and other rare conditions, leveraging their expertise in structure-guided drug design.

Where Is BioCryst Pharmaceuticals, Inc.'s Headquarters?

BioCryst Pharmaceuticals, Inc. officeBioCryst Pharmaceuticals, Inc. officeBioCryst Pharmaceuticals, Inc. officeBioCryst Pharmaceuticals, Inc. office
*Images sourced via web search. Rights belong to original owners

HQ Function

The Durham headquarters serves as the central hub for executive leadership, research and development (R&D) operations, clinical development, corporate strategy, finance, legal, and administrative functions.

Notable Features:

Located within a modern business park, the facility is likely equipped with state-of-the-art laboratory spaces for drug discovery and development, along with contemporary office environments designed to foster collaboration and innovation.

Work Culture:

The work culture at BioCryst's headquarters is likely characterized by a strong scientific focus, collaboration, and a patient-centric mission. Employees are driven by the opportunity to make a significant impact on the lives of individuals with rare diseases.

HQ Significance:

Its location in Research Triangle Park provides access to a rich ecosystem of academic institutions, skilled talent, and other life science companies, fostering innovation and partnerships. It's central to their US operations and global R&D strategy.

Values Reflected in HQ: The headquarters likely reflects BioCryst's core values such as scientific excellence, innovation, integrity, patient focus, and collaboration, evident in its design and operational focus.

Location:

BioCryst Pharmaceuticals supports its global operations through its headquarters in Durham, NC, and key international offices in Dublin, Ireland (EMEA hub) and Tokyo, Japan (Asia-Pacific hub). These locations enable the company to conduct global clinical trials, manage regulatory affairs across multiple jurisdictions, and commercialize its approved therapies, such as ORLADEYO®, in North America, Europe, and Asia. Their presence facilitates engagement with local healthcare providers, patient advocacy groups, and regulatory bodies worldwide.

Street Address:

4505 Emperor Blvd, Suite 200

City:

Durham

State/Province:

North Carolina

Country:

USA

Where Else Does BioCryst Pharmaceuticals, Inc. Operate Around the World?

Dublin, Ireland

Address: Block C, Iveagh Court, Harcourt Road, Dublin 2, Ireland

To support the launch and commercialization of ORLADEYO® and future products across the EMEA region, engage with European healthcare systems, and manage regional clinical trial activities.

Tokyo, Japan

Address: Toranomon Hills Mori Tower, 1-23-1 Toranomon, Minato-ku, Tokyo 105-6322, Japan

To navigate the Japanese regulatory landscape, conduct clinical trials tailored to the local population, and build a commercial presence to bring therapies like ORLADEYO® to patients in Japan.

New York, New York, USA

Address: Information on a specific large office in New York is not prominently listed, but companies often have smaller, strategic presences or use flexible office spaces for specific functions like investor relations or business development.

Facilitating engagement with the financial community, potential partners, and strategic stakeholders based in the New York metropolitan area.

Buying Intent Signals for BioCryst Pharmaceuticals, Inc.

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading BioCryst Pharmaceuticals, Inc.? Meet the Executive Team

As of April 2025, BioCryst Pharmaceuticals, Inc.' leadership includes:

Jon P. Stonehouse - President and Chief Executive Officer
Anthony J. Gibney - Chief Financial Officer
Dr. William P. Sheridan - Chief Development Officer
Dr. Helen Thackray - Chief Research and Development Officer
Alane P. Barnes - Chief Legal Officer & Corporate Secretary
Charles Gayer - Chief Commercial Officer
Megan Sniecinski - Chief Business Officer
Jinky Rosselli - Chief Data and Insights Officer
Margo Heath-Chiozzi - Senior Vice President, Chief Regulatory and Quality Officer

Who's Investing in BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. has been backed by several prominent investors over the years, including:

Baker Bros. Advisors LP
The Vanguard Group, Inc.
BlackRock, Inc.
State Street Corporation
RA Capital Management, L.P.
Deep Track Capital, LP
Perceptive Advisors LLC

What Leadership Changes Has BioCryst Pharmaceuticals, Inc. Seen Recently?

Hire3
Exits0

BioCryst Pharmaceuticals has made several strategic appointments and promotions to strengthen its leadership team over the past year, particularly in business development, data insights, and regulatory affairs, reflecting its growth and focus on commercialization and pipeline advancement. No major C-suite departures were prominently announced.

New Appointments:

Megan Sniecinski, Megan Sniecinski was appointed as Chief Business Officer to lead business development and strategic partnerships.
Jinky Rosselli, Jinky Rosselli joined BioCryst as the new Chief Data and Insights Officer, a new role focused on leveraging data analytics.
Margo Heath-Chiozzi, Margo Heath-Chiozzi was appointed as SVP, Chief Regulatory and Quality Officer.

What Technology (Tech Stack) Is Used byBioCryst Pharmaceuticals, Inc.?

Discover the tools BioCryst Pharmaceuticals, Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

BioCryst Pharmaceuticals, Inc. Email Formats and Examples

BioCryst Pharmaceuticals primarily uses the email format combining the first initial and last name. Variations may exist, but this is the most common structure.

[first_initial][last]@biocryst.com

Format

jdoe@biocryst.com

Example

85%

Success rate

What's the Latest News About BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals • May 7, 2024

BioCryst Pharmaceuticals news title: BioCryst Reports First Quarter 2024 Financial Results and Reiterates Full Year ORLADEYO® Net Revenue Guidance

BioCryst announced its financial results for Q1 2024, highlighting $80.2 million in ORLADEYO net revenue. The company reaffirmed its full-year 2024 ORLADEYO net revenue guidance of $380 million to $400 million and expects continued patient growth....more

BioCryst Pharmaceuticals • April 1, 2024

BioCryst Pharmaceuticals news title: BioCryst Announces New Data on ORLADEYO® (berotralstat) and HAE to Be Presented at AAAAI 2024 Annual Meeting

BioCryst announced that new data on ORLADEYO, including analyses on long-term efficacy, patient-reported outcomes, and real-world evidence, would be presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2024 Annual Meeting....more

BioCryst Pharmaceuticals • February 21, 2024

BioCryst Pharmaceuticals news title: BioCryst Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance

BioCryst reported its Q4 and full-year 2023 financial results, with ORLADEYO net revenue of $326.6 million for 2023. The company provided its 2024 financial outlook, emphasizing continued growth for ORLADEYO and advancement of its pipeline....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including BioCryst Pharmaceuticals, Inc., are just a search away.